Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Lifestyle Health and Longevity

80% of People Are Deficient in Essential Vitamins — Here Are the 10 You Actually Need and Where to Get Them

by Team Lumida
July 27, 2026
in Health and Longevity
Reading Time: 4 mins read
A A
0
oranges, peas, and limes on a wooden table

Photo by Madara on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp
  • Fat-soluble vitamins — A, D, E, and K — are foundational to physical structure and protection: Vitamin A drives cell development and is essential for healthy hair, teeth, nails, skin, and bones (found in salmon, cold-water fish, fortified dairy, and egg yolk); Vitamin D supports teeth and bone health and is obtained from fortified milk, soy, butter, egg yolk, fatty fish, and fish-liver oil; Vitamin E maintains muscle strength and antioxidant function (eggs, nuts, vegetable oils, fortified cereals); and Vitamin K is critical for blood clotting — a deficiency can cause dangerous clotting failures — and is found in spinach, broccoli, leafy greens, and chicken liver; these four vitamins are stored in body fat and liver, meaning both deficiency and excess can have serious long-term health consequences.
  • Water-soluble B vitamins and Vitamin C handle metabolism, immunity, and cellular repair on a daily basis since they are not stored in the body and must be continuously replenished through diet: Vitamin C promotes wound healing, strengthens blood vessel walls, boosts immunity, and acts as an antioxidant — sources include citrus fruits, berries, broccoli, potatoes, and melons; Vitamin B1 (thiamine) supports healthy metabolism, appetite regulation, and nerve function — found in pork, legumes, nuts, grains, and fortified cereals; and folic acid is especially critical for pregnant women as it supports proper nerve and brain development in the fetus, with avocado, banana, spinach, and Brussels sprouts being the best dietary sources.
  • Three minerals work alongside vitamins to complete the body’s essential nutrient profile: iron enables red blood cells to transport oxygen to vital organs and tissues — kidney beans, baked potatoes, nuts, and peas are strong sources; zinc boosts immune function and accelerates wound healing — legumes, lentils, chickpeas, seeds, eggs, nuts, and whole grains all contribute; and omega-3 fatty acids support both cardiovascular health and mental health — found primarily in fatty fish and fish oil supplements; the adult body requires these minerals in consistent daily amounts, and deficiencies in all three are among the most common nutritional shortfalls globally, particularly in populations relying heavily on processed foods.
  • Daily requirements vary meaningfully by age and gender: men aged 50-70 need approximately 1,000 mg of combined vitamins and minerals per day, while women in the same age group require around 1,200 mg — a gap driven primarily by calcium and bone-density needs; roughly 80% of people fail to meet these requirements consistently, largely because fast food and processed diets deliver calories without micronutrients; a diet anchored in fatty fish, leafy greens, legumes, eggs, nuts, dairy, and citrus fruits covers the majority of essential vitamin and mineral requirements without supplementation for most healthy adults, and diagnostic testing can identify specific deficiencies before supplementing — since targeted supplementation based on actual lab values is more effective and safer than broad-spectrum multivitamins taken without baseline data.

What Happened?

Nutritional deficiency remains one of the most widespread and underappreciated health risks globally, with an estimated 80% of people failing to meet daily vitamin and mineral requirements. Modern diets heavy in processed and fast foods deliver caloric density without the micronutrient content the body requires for immune function, bone health, metabolism, cardiovascular health, and cellular repair. The 13 essential vitamins — split between fat-soluble (A, D, E, K) and water-soluble (B-complex and C) — along with key minerals like iron and zinc and essential fats like omega-3s, form the nutritional foundation that most diets are quietly depleting.

Why It Matters?

Vitamin and mineral deficiencies don’t announce themselves dramatically — they accumulate slowly as immune resilience drops, wound healing slows, energy metabolism falters, and bone density declines. The economic cost of deficiency-related illness, from increased infection susceptibility to osteoporosis to cardiovascular disease, runs into hundreds of billions of dollars annually in healthcare systems worldwide. Nutritional status is a highly modifiable health variable, and routine diagnostic testing can now quantify individual deficiencies with precision — making targeted dietary intervention more accessible than ever.

What’s Next?

For individuals, the practical step is to build meals around high-density sources — fatty fish, leafy greens, legumes, eggs, nuts, citrus fruits, and fortified dairy — and consider diagnostic testing to establish a personal baseline before supplementing. For the healthcare and diagnostics sector, nutritional deficiency screening is a growing category as preventive health gains traction among younger demographics and employer wellness programs expand beyond traditional biometrics into comprehensive micronutrient panels.

Source: Apollo Diagnostics

Previous Post

Trump Pauses Iran Strike Campaign as Munitions Stocks Run Low and Diplomacy Stalls

Recommended For You

Whoop Enters Clinical Care With Joint Replacement Recovery Pilot — Can Wearable Biometrics Reduce Opioids and Speed Recovery?

by Team Lumida
7 days ago
a close up of a human skull on a black background

Whoop and surgical software company Kinomatic have launched a 12-week pilot program called Restore across three California orthopedic clinics to test whether continuous biometric monitoring — heart rate...

Read more

$399 Signal Ring Claims to Replace the Blood Pressure Cuff — No Calibration, No Subscription, Clinical Trial at Stanford

by Team Lumida
2 weeks ago
Fingers hold a black smart ring with circuits visible.

Vital Signals, a three-year-old startup, has launched a $399 Signal Ring that claims to track blood pressure as accurately as a traditional arm cuff — without requiring any...

Read more

Novo’s Obesity Pill Commands 89% Market Share — Lilly’s Foundayo Captures Just 11% After Three Months on Market

by Team Lumida
2 weeks ago
Novo’s Obesity Pill Commands 89% Market Share — Lilly’s Foundayo Captures Just 11% After Three Months on Market

Novo Nordisk's Wegovy pill has seized 89% of new oral obesity pill prescriptions since its January 2026 launch, leaving Eli Lilly's Foundayo — launched in April — with...

Read more

Information Blocking in Healthcare Is Down — But a Stubborn Minority of IT Vendors Keep Doing It Routinely

by Team Lumida
2 weeks ago
doctor holding red stethoscope

The share of health information exchanges reporting instances of information blocking fell from over 90% in 2019 to 71% in 2025, according to new ONC data — but...

Read more

Novo Nordisk Squeezes Suppliers for Discounts as Eli Lilly Eats Its Lunch in the Obesity Drug Market

by Team Lumida
4 weeks ago
Novo Nordisk Q2 2024 Earnings Highlights

Novo Nordisk has written to suppliers seeking price discounts to protect its cost base as it fights to claw back market share lost to Eli Lilly in the...

Read more

Medicare Launches $50/Month Weight-Loss Drug Coverage Today — With Caveats

by Team Lumida
4 weeks ago
GLP-1 Drugs Are Triggering a Returns Crisis for America’s Apparel Retailers

Medicare's "Bridge" program kicks off July 1, offering Wegovy and Zepbound to 12.5–20 million eligible seniors at a $50 monthly copay — down from up to $450 cash...

Read more

FDA Reverses Rejection of Regenxbio Gene Therapy for Fatal Rare Disease

by Team Lumida
1 month ago
FDA Reverses Rejection of Regenxbio Gene Therapy for Fatal Rare Disease

The FDA agreed to reverse its rejection of Regenxbio's Navsunli gene therapy for Hunter syndrome — the third rare-disease drug reversal under new FDA leadership, marking a retreat...

Read more

Nvidia Partners With Abridge to Build an AI Model Trained on Real Doctor-Patient Conversations

by Team Lumida
1 month ago
Nvidia’s AI Demand Surge: Hon Hai Ramps Up Server Production

Nvidia and AI medical note-taking startup Abridge are jointly developing a clinical AI model trained on de-identified doctor-patient conversations, using Nvidia's open Nemotron models as a base —...

Read more

Nearly 90% of Americans Have It and Don’t Know It: First Guidelines Issued for CKM Syndrome

by Team Lumida
2 months ago
people holding us a flag during daytime

The American Heart Association and three major medical societies published the first clinical guidelines for cardiovascular-kidney-metabolic syndrome — a cluster of interconnected conditions tied to excess body fat...

Read more

Employers Are Slashing GLP-1 Coverage as Costs Spiral — And Some Are Adding Weigh-Ins to Keep It

by Team Lumida
2 months ago
GLP-1 Drugs Are Triggering a Returns Crisis for America’s Apparel Retailers

More than a quarter of large companies are adding new criteria for GLP-1 weight-loss coverage while 11% are dropping it altogether, as drug costs balloon and employers struggle...

Read more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

white and black quadcopter hovering under blue skies

Can Taiwan Build a Drone Army Without Relying on China?

June 24, 2024
Why Apple’s AI Approach May Save Its Reputation

Apple’s AI Struggles Persist as WWDC Fails to Deliver Major Breakthroughs

June 10, 2025
Tesla Stock Plunges After UBS Downgrade

Tesla’s EU Sales Plunge 47% in February Amid Industry-Wide Electric Vehicle Surge

March 25, 2025

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto data centers Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Intel Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018